PON1 and rheumatoid arthritis: The levels of HDL-associated antioxidant enzyme, paraoxonase (PON), are abbreviated in RA patients as compared to controls [99], whereas an investigation revealed that alterations in the antioxidant function of HDL were observed, expressed by elevated PON, following therapy with TNF-α inhibitor [153].